Company Monitoring Page for Roche

latest headlines for company on cafepharma

10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
Tags:
FDA, clinical trials, Sarepta Therapeutics, Bridge Bio, Sanofi, Merck KGaA, Pfizer, Novo Nordisk, Verve Therapeutics, Roche, Vertex Pharmaceuticals, JNJ, Bristol Myers Squibb, ATTR-CM, Elevidys, tolebrutinib, evobrutinib, danuglipron, tiragolumab, VX-548, lazertinib
Novo Nordisk's phase 3 data for hemophilia hopeful fail to shake off Pfizer's shadow
Fierce Biotech
Tue, 06/27/23 - 10:36 pm
Tags:
Novo Nordisk, hemophilia, clinical trials, Pfizer, Roche, Hemlibra
Roche drops antisense drug after seeing efficacy data, leaving Biogen, Ionis and Ultragenyx to duke it out
Fierce Biotech
Fri, 06/23/23 - 09:46 am
Tags:
Roche, Angelman Syndrome, antisense, Biogen, Ionis Pharmaceuticals, Ultragenyx, rugonersen
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
Tags:
IPF, Roche, Esbriet, Pirespa, Boehringer Ingelheim, Ofev
Roche follows AbbVie with FDA approval for dual-targeting lymphoma drug
BioPharma Dive
Fri, 06/16/23 - 09:57 am
Tags:
Roche, Columvi, FDA, relapsed or refractory diffuse large B-cell lymphoma, blood cancer
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
Tags:
biosimilars, biologics, drug pricing, Roche, Herceptin, Amgen, Kanjinti, Viatris, Ogivri, Pfizer, Trazimera, Teva Pharmaceutical, Herzuma, Organon, Ontruzant
ASCO: Merck's Keytruda trips in EGFR lung cancer as Roche's Tecentriq fails in kidney cancer
Fierce Pharma
Tue, 06/6/23 - 04:19 pm
Tags:
ASCO 2023, Merck, Keytruda, EGFR lung cancer, Roche, Tecentriq, kidney cancer
Nykode collaborates with Roche for an upcoming trial in cervical cancer
Clinical Trials Arena
Thu, 06/1/23 - 11:24 am
Tags:
Nykode Therapeutics, Roche, cervical cancer, VB10.16, clinical trials
Roche looking to sell or shut down California biologic drug plant
Reuters
Thu, 06/1/23 - 11:21 am
Tags:
Roche, Genentech, California, drug manufacturing
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wed, 05/31/23 - 11:15 am
Tags:
layoffs, Rain Oncology, Takeda, PTC Therapeutics, Affimed, Urovant Sciences, Roche, Novavax, Gossamer Bio, Bristol Myers Squibb, ADC Therapeutics
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
Roche Terminates Second Phase II Schizophrenia Trial
BioSpace
Tue, 05/23/23 - 11:24 am
Tags:
Roche, schizophrenia, ralmitaront, clinical trials
Gilead picks former Roche executive to run cell therapy unit Kite
BioPharma Dive
Wed, 05/17/23 - 11:14 am
Tags:
Gilead Sciences, Roche, Kite Pharma, cell therapy, Cindy Perettie, women executives
Roche’s BTK inhibitor succeeds in a Phase II MS trial
Clinical Trials Arena
Wed, 05/17/23 - 10:07 am
Tags:
Roche, fenebrutinib, clinical trials, MS, relapsing multiple sclerosis
Big Pharma layoffs: BMS, Roche and Takeda axe hundreds of jobs
Medical Marketing and Media
Mon, 05/15/23 - 10:04 am
Tags:
layoffs, Bristol Myers Squibb, Roche, Takeda, Gossamer Bio, Novavax
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches, AbbVie, Almirall, Apellis Pharmaceuticals, Astellas, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eli Lilly, Genmab, GSK, Iveric Bio, Pfizer, Roche, SAGE Therapeutics, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Vertex Pharmaceuticals
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
Thu, 05/11/23 - 10:08 am
Tags:
BioNTech, Roche, Genentech, pancreatic cancer, MRNA, Nature, vaccines
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Tags:
Gilead Sciences, GSK, momelotinib, Roche, Eli Lilly, lebrikizumab, Merck, Zejula, Amgen, Galenica, Veltassa, Cubicin
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Gilead Sciences, Horizon Therapeutics, Merck, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Tue, 05/9/23 - 12:27 pm
Tags:
Roche, Genentech, FDA, Vabysmo, macular edema, retinal vein occlusion

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.